• A 17-month-old girl with fetal valproate syndrome and ocular coloboma
• A newborn with convulsions 12 days after birth was misdiagnosed as neonatal intracranial hemorrhage: Case report
• Cholesterol deficiency as a mechanism for autism: A valproic acid model
• Clinical Effect of Nimodipine Combined with Magnesium Sulfate on Pregnancy-Induced Hypertension Syndrome
• Current management of neonatal abstinence syndrome: a survey of practice in the UK and Ireland
• Dental and oro-facial features of Foetal Anticonvulsant Syndrome
• Dyke-davidoff-masson syndrome: A case report of an adolescent boy at a tertiary hospital in Adamawa, North-Eastern Nigeria
• Effectiveness of nutritional interventions to prevent nonprogressive congenital and perinatal brain injuries: a systematic review and meta-analysis of randomized trials
• Epigenetic mechanisms involved in the genesis of autism
• Fetal exposure to valproic acid dysregulates the expression of autism-linked genes in the developing cerebellum
• Fetal valproate syndrome with coronary arteriovenous fistula: a case report
• Folic acid supplementation rescues valproic acid-induced developmental neurotoxicity and behavioral alterations in zebrafish embryos
• Haemolysis, elevated liver enzymes and low platelets: Diagnosis and management in critical care
• HELLP Syndrome at 20 Gestational Weeks Managed Using the Mississippi Protocol: A Case Report
• HELLP syndrome manifesting as abnormal fetal umbilical artery blood flow and rapidly worsening laboratory indexes: A case report
• Hyperammonemic encephalopathy induced by valproic acid
• Magnesium sulfate in preeclampsia: Broad indications, not only in neurological symptoms
• MERRF
• Nebulized Magnesium Sulfate for Treatment of Persistent Pulmonary Hypertension of Newborn: A Pilot Randomized Controlled Trial
• Neurodevelopmental outcomes in children and adults with Fetal Valproate Spectrum Disorder: A contribution from the ConcePTION project
• New valproate regulations, informed choice and seizure risk
• NRF2 activation protects against valproic acid-induced disruption of neurogenesis in P19 cells
• Perioperative pharmacological interventions for fetal immobilisation during fetal surgery and invasive procedures
• Prenatal dispositions and genetic analysis of monozygotic female twins with suprasellar cysts and hydrocephalus: A case report
• Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM
• The lived experience of young adults with Fetal Valproate Spectrum Disorder, and the perspective of their parents: A qualitative study
• Utility of Nebulized Magnesium Sulfate Therapy for Persistent Pulmonary Hypertension of Newborn
• Valproic Acid in Pregnancy Revisited: Neurobehavioral, Biochemical and Molecular Changes Affecting the Embryo and Fetus in Humans and in Animals: A Narrative Review